Self-immolative PEGylated dendritic drug conjugates for cancer therapy with enhanced cellular uptake
Chemical Communications · 2025 · 61 (57) · 10590-10593
DOI: 10.1039/d5cc02776d ↗At a glance
Journal article in Chemical Communications, 2025. Written by Zining Xia and 5 co-authors. Institution: School of Chemistry and Chemical Engineering, Nantong University, Nantong, 226019, P. R. China. yueding@ntu.edu.cn. Major MEDLINE topics: Porphyrins, Dendrimers, Polyethylene Glycols, Antineoplastic Agents. Cited 5 times so far (Crossref); 36 references. Funded by: Natural Science Foundation of Jiangsu Province.
Abstract (original language)
A hypoxia-responsive nanomedicine NM-CB/Ce6 was prepared using a self-immolative PEGylated dendritic drug conjugate block-dendritic-polymer for photodynamic-chemotherapy synergistic therapy with enhanced cellular internalization.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- School of Chemistry and Chemical Engineering, Nantong University, Nantong, 226019, P. R. China. yueding@ntu.edu.cn.
- School of Pharmacy, Nantong University, Nantong, 226019, P. R. China.
Funding
- Natural Science Foundation of Jiangsu Province
Cite
APA
Xia, Z., Zhang, Y., Zuo, X., Cheng, S., Tian, Y., & Ding, Y. (2025). Self-immolative PEGylated dendritic drug conjugates for cancer therapy with enhanced cellular uptake. Chemical Communications, 61(57), 10590-10593. https://doi.org/10.1039/d5cc02776d
Vancouver
Xia Z, Zhang Y, Zuo X, Cheng S, Tian Y, Ding Y. Self-immolative PEGylated dendritic drug conjugates for cancer therapy with enhanced cellular uptake. Chemical Communications. 2025;61(57):10590-10593. doi:10.1039/d5cc02776d
BibTeX
@article{Xia2025,
author = {Xia, Zining and Zhang, Yixin and Zuo, Xinyi and Cheng, Sucan and Tian, Yanwen and Ding, Yue},
title = {Self-immolative PEGylated dendritic drug conjugates for cancer therapy with enhanced cellular uptake},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {57},
pages = {10590--10593},
doi = {10.1039/d5cc02776d}
}
EUVIMED